Inventor · disambiguated record
Srinivasan Ramanathan
Also filed as: RAMANATHAN SRINIVASAN
1 granted patent·10 pending applications·2 citations·filing 2002–2016
24Inventor score
Top patents by PatentIndex Score
11 records- 0173US7740882B2Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agentsRAMANATHAN SRINIVASAN·Filed 2005·Granted Jun 22, 2010·2 cites·11 claims
- 0252US2009093467A1Therapeutic compositions and methodsGILEAD SCIENCES INC·Filed 2008·Application pending·0 cites
- 0349US2014343063A1Method of treating a viral infection using elvitegravir combinationsGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 0448US2011087004A1Enhanced oral transcompartmental delivery of therapeutic or diagnostic agentsRAMANATHAN SRINIVASAN·Filed 2010·Application pending·0 cites
- 0547US2013072447A1Enhanced oral transcompartmental delivery of therapeutic or diaganostic agentsRAMANATHAN SRINIVASAN·Filed 2012·Application pending·0 cites
- 0647US2010331331A1Therapeutic compositions and the use thereofTHERAPEUTIC COMPOSITONS AND USE THEREOF·Filed 2008·Application pending·0 cites
- 0746US2015105350A1Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infectionsGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 0843US2017136001A1Method of treating a viral infection using elvitegravir combinationsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 0942US2017056423A1Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infectionsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 1038US2018353512A1Combination therapies for treating b-cell malignanciesGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 1135US2003091640A1Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agentsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Srinivasan Ramanathan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →